Biotechnology
Firmenich & Novozymes partner for great-tasting yogurt with unprecedented sugar reduction performance
New TasteGEM® SWL with Saphera® enables up to 50% sugar reduction without the use of sweeteners - while keeping a natural sweet taste GENEVA, Oct. 7, 2020 /PRNewswire/ -- Sugar reduction leader Firmenich, the world's largest privately owned perfume and taste company, and Danish biological soluti...
2020-10-07 20:00
4136
Nagase R&D Center Increases Productivity of Rare Amino Acid "Ergothioneine" 1000-fold: Highest Production Efficiency Reported Using "Smart Cell" Technology
TOKYO, Oct. 7, 2020 /PRNewswire/ -- The Nagase R&D Center, the research and development arm of NAGASE & CO., LTD. based inTokyo, has been developing fermentative production technology for ergothioneine (EGT) (*1) and researching EGT's functions. Using revolutionary biotechnology developed as part...
2020-10-07 14:00
2104
First Commercial Drug Manufactured via Ajinomoto Bio-Pharma Services' AJIPHASE Technology Receives FDA Approval
TOKYO, Oct. 6, 2020 /PRNewswire/ -- Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma"), a leading provider of biopharmaceutical contract development and manufacturing services, is pleased to announce that the US FDA has approved the first commercial drug manufactured via Aji Bio-Pharma's proprietar...
2020-10-06 22:20
3304
Thailand's Eastern Economic Corridor to Become Post-COVID Global Food Innovation Hub
BANGKOK, Oct. 6, 2020 /PRNewswire/ -- Thailand's high-tech Eastern Economic
Corridor (EEC), already positioning itself as the gateway toAsia, is aiming for
a new post-COVID-19 role as incubator of innovative food products to nourish
the world, officials said.
2020-10-06 12:18
5472
CARsgen Therapeutics Granted Orphan Drug Designation by the US FDA for CT041 CLDN18.2 CAR-T Cells for the Treatment of Gastric and Gastroesophageal Junction Cancers
SHANGHAI, Oct. 5, 2020 /PRNewswire/ -- CARsgen Therapeutics Co., Ltd., a clinical-stage biopharmaceutical company, today announced thatthe United States (US) Food and Drug Administration (FDA) has granted orphan drug designation to one of CARsgen's first-in-class drug candidates, CT041, for the t...
2020-10-05 18:00
5255
Happiness Biotech Announced Receipt of FDA Registration For Its Hand Sanitizer
NANPING, China, Oct. 1, 2020 /PRNewswire/ -- Happiness Biotech Group Limited (the "Company" or Nasdaq: HAPP), an innovativeChina-based nutraceutical and dietary supplements producer, announced today that the Company's hand sanitizer products have been registered with U.S. Food and Drug Administra...
2020-10-01 22:00
13032
OriCiro Launches World's First Cell-Free Amplification Technology for Large Circular DNA
TOKYO, Sept. 30, 2020 /PRNewswire/ -- OriCiro Genomics, a pioneer in the cell-free synthesis and amplification of genome-scale large DNA for gene therapy and synthetic biology, has today launched the OriCiroTM Cell-Free Cloning System, the world's first technology enabling cell-free amplification...
2020-09-30 21:47
3208
Firmenich Opens New Era in Ingredient Creation with Launch of Biotech and Naturals Pilot Plant in Geneva
GENEVA, Switzerland, Sept. 30, 2020 /PRNewswire/ -- Firmenich, the world's largest privately-owned Perfume and Taste company, is proud to announce the opening of its new biotechnology and naturals pilot plant and laboratory in Geneva. Benefiting from the latest digital technology, the facility ope...
2020-09-30 21:36
3727
TaiGen Biotechnology Out-Licensed Taigexyn (Nemonoxacin) to Luminarie Canada for Canada, Australia and New Zealand
TAIPEI, Sept. 30, 2020 /PRNewswire/ -- TaiGen Biotechnology Company, Limited ("TaiGen")(Taiwan: 4157) today announced that they have signed an exclusive licensing agreement with Luminarie Canada Inc. ("Luminarie"), a leading Canadian pharmaceutical company, to develop and commercialize Taigexyn® ...
2020-09-30 15:51
1859
ILIAS Biologics Closes $20.6 Million Series B Financing
DAEJEON, South Korea, Sept. 28, 2020 /PRNewswire/ -- ILIAS Biologics Inc. (the "Company" or "ILIAS"), a leading exosome-based therapeutics company, announced today that the Company has completed a Series B financing round of$20.6 million inSouth Korea. The initial investors from the Series A rou...
2020-09-28 19:00
1716
World's first clinical trial of non-viral PD1 specific targeted CAR T therapy achieves great breakthroughs
SHANGHAI, Sept. 28, 2020 /PRNewswire/ -- On September 25, 2020, BIORAY LABORATORIES Inc. ("Bioraylab"), a company specialized in gene therapy and cell drug R&D, announced for the first time that clinical trials of non-viral PD1 specific targeted CAR T therapy in relapsed/refractory B-cell non-Hod...
2020-09-28 19:00
1589
Carmine Therapeutics named as one of FierceBiotech's "Fierce 15" Biotech Companies of 2020
CAMBRIDGE, Mass., Sept. 28, 2020 /PRNewswire/ -- Carmine Therapeutics announced today that it has been named by FierceBiotech as one of 2020's Fierce 15 biotechnology companies, designating it as one of the most promising private biotechnology companies in the industry. The 2020 Fierce 15 com...
2020-09-28 18:00
1438
TYVYT® (Sintilimab Injection) in Combination with BYVASDA® (Bevacizumab Injection) ORIENT-32 Study Met Its Primary Endpoints of Progression-Free Survival and Overall Survival in the First-Line Treatment of Patients with Advanced Hepatocellular Carcinoma (HCC)
SAN FRANCISCO and SUZHOU, China, Sept. 28, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, metabolic, autoimmune and other major d...
2020-09-28 10:15
6286
InventisBio Announces $147 Million Series D Financing Led by Hillhouse Affiliate GL Ventures
SHANGHAI, Sept. 28, 2020 /PRNewswire/ -- InventisBio, a clinical stage biotech company dedicated to the research and development of innovative small molecule drugs, announced the recent completion of a$147 million series D financing which has attracted participation of many top biopharmaceutical ...
2020-09-28 05:00
4283
Radius Health & Menarini Group Provide Elacestrant Update
Target enrollment milestone reached in the Phase 3 EMERALD study Life cycle planning advancing in parallel with current Phase 3 monotherapy program WALTHAM, Mass. and FLORENCE, Italy, Sept. 25, 2020 /PRNewswire/ -- -Radius Health, Inc. ("Radius" or the "Company") (Nasdaq: RDUS) and the Menari...
2020-09-25 18:15
7172
Neurophth Therapeutics' Treatment of Leber's Hereditary Optic Neuropathy Gene Therapy NR082 was Granted Orphan Drug Designation by U.S. FDA
NEWARK, Del., Sept. 24, 2020 /PRNewswire/ -- Neurophth Therapeutics, Inc., (hereinafter referred to as "Neurophth") today announced that its leading candidate, NR082 (rAAV2-ND4, NFS-01 project), was granted an orphan drug designation (ODD) by the U.S. FDA for the treatment of Leber's Hereditary O...
2020-09-25 10:37
2323
Cell Signaling Technology Named a Top Charitable Company in Massachusetts by the Boston Business Journal
DANVERS, Massachusetts, Sept. 24, 2020 /PRNewswire/ -- Cell Signaling Technology, Inc. (CST), a discovery technology company and leading provider of antibodies, kits, and services, was named by the Boston Business Journal (BBJ) for the 5th year in a row, as a 2020 top corporate charitable contrib...
2020-09-24 20:00
3809
KYAN Therapeutics Exclusively Licenses Small Molecule HDAC Inhibitors for AI-Powered Cancer Drug Development
SINGAPORE, Sept. 24, 2020 /PRNewswire/ -- KYAN Therapeutics, Inc. ("KYAN"), a frontier biotech company with a novel drug-dose combination optimizing platform, Optim.AI, has entered into an exclusive license agreement with Georgetown University for novel selective Class II HDAC inhibitors. KYAN has...
2020-09-24 17:12
1744
Macrogen, K-Quarantine System "Smart Mobile Lab" Exported to Indonesia
SEOUL, South Korea, Sept. 24, 2020 /PRNewswire/ -- Macrogen has established the
first "Smart Mobile Lab" in Korea and has supplied it toIndonesia as well.
2020-09-24 09:00
4581
SEMI-NBMC Invites White Paper Proposals for Funding of Human Monitoring Innovations
MILPITAS, California, Sept. 23, 2020 /PRNewswire/ -- SEMI Nano-Bio Materials Consortium (NBMC) today released a Request for Proposals (RFP) for innovations in ambulatory monitoring, wearable technologies for cognitive assessment, and innovative power sources for wearable monitors. Proposals are a...
2020-09-24 07:11
2022
Week's Top Stories
Most Reposted
Rocket Travel by Agoda Shares Revealing New Report and Showcases Solution to Transform Hotel Distribution
[Picked up by 313 media titles]
2024-11-21 10:30Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 308 media titles]
2024-11-20 13:29Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 301 media titles]
2024-11-20 16:30
Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
[Picked up by 284 media titles]
2024-11-20 09:00
Most Read
Strategic Forum in Chongqing Drives Expansion of New Western Land-Sea Corridor
2024-11-16 14:15
5216
